Xiaolan Chang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 2
-
- Nuclear Receptors and Signaling 2
- Co-authors
- Dongyang Huang (14 shared papers)Xuhong Song (14 shared papers)Xiaoyang Jiao (7 shared papers)Zhongjing Su (5 shared papers)Qingdong Xie (4 shared papers)Yazhen Li (4 shared papers)Bin Liang (4 shared papers)Ting Su (5 shared papers)
- Journals
- Disease Markers (2 papers)Clinical Science (2 papers)Hematological Oncology (1 paper)Virus Research (1 paper)Technology in Cancer Research & Treatment (1 paper)
- Partner nations
- China
In The Last Decade
Xiaolan Chang
21 papers receiving 540 citations
Peers
Comparison fields: 5 of 64
- Cancer Research 147
- Geriatrics and Gerontology 20
- Neurology 31
- Hematology 36
- Molecular Biology 162
Countries citing papers authored by Xiaolan Chang
This map shows the geographic impact of Xiaolan Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolan Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolan Chang more than expected).
Fields of papers citing papers by Xiaolan Chang
This network shows the impact of papers produced by Xiaolan Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolan Chang. The network helps show where Xiaolan Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaolan Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 82 | |
| 2 | 2015 | 49 | |
| 3 | 2016 | 45 | |
| 4 | 2021 | 44 | |
| 5 | 2014 | 40 | |
| 6 | Vimentin acetylation is involved in SIRT5-mediated hepatocellular carcinoma migration. | 2018 | 38 |
| 7 | 2019 | 37 | |
| 8 | 2019 | 35 | |
| 9 | 2016 | 27 | |
| 10 | 2018 | 25 | |
| 11 | 2019 | 24 | |
| 12 | 2019 | 21 | |
| 13 | 2015 | 17 | |
| 14 | 2015 | 15 | |
| 15 | 2015 | 15 | |
| 16 | 2019 | 15 | |
| 17 | 2011 | 7 | |
| 18 | 2014 | 6 | |
| 19 | 2012 | 3 | |
| 20 | [Effect of the cryopreserved Schwann cells on the peripheral nerve regeneration]. | 2003 | 1 |
About Xiaolan Chang
Xiaolan Chang is a scholar working on Cancer Research, Cellular and Molecular Neuroscience, Molecular Biology, Hematology and Geriatrics and Gerontology, having authored 22 papers that have together received 547 indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (4 papers), Cancer-related molecular mechanisms research (4 papers), Nuclear Receptors and Signaling (2 papers), MicroRNA in disease regulation (2 papers), Retinoids in leukemia and cellular processes (2 papers), Bioactive Compounds and Antitumor Agents (1 paper), Inflammatory mediators and NSAID effects (1 paper) and Cholesterol and Lipid Metabolism (1 paper). The work is most often cited by research in Cancer Research (147 citations), Geriatrics and Gerontology (20 citations), Neurology (31 citations), Hematology (36 citations) and Molecular Biology (162 citations). Xiaolan Chang has collaborated with scholars based in China. Frequent co-authors include Dongyang Huang, Xuhong Song, Xiaoyang Jiao, Zhongjing Su, Qingdong Xie, Yazhen Li, Bin Liang, Ting Su, Xina Xie and Dongyang Huang. Their work appears in journals such as Disease Markers, Clinical Science, Hematological Oncology, Virus Research and Technology in Cancer Research & Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.